|
Welcome.
|
|
Welcome to the Autumn issue of MIP Technologies’ Newsletter.
In this issue of the Newsletter you can read about new applications for Chloramphenicol extraction from urine and honey samples. You can also read about the discovery, by ExploraSep™, of a selective phase for the antidepressant medicines fluoxetine and paroxetine.
MIP Technologies was present at MIP 2006 in Cardiff and we have summarized highlights from the meeting including MIPs developed for various solid-phase extraction applications.
I hope you will enjoy the reading and wish you all a good Autumn!
Christine Widstrand
VP Sales & Marketing
MIP Technologies AB
|
|
|
Fast and efficient extractions of Chloramphenicol from urine and honey
|
|
MIP[4]SPE Chloramphenicol efficiently extracts Chloramphenicol from several different matrices. Applications for extractions from urine, honey and milk are now available. The methods are fast, about 1.5 hours. Detection limits well below the minimum required performance limit (MRPL) for Chloramphenicol are achieved, enhancing the reliability of the detection and ensuring improved food safety and quality.
 Read more (.pdf)
Application notes for extraction of Chloramphenicol from honey, urine and milk can also be downloaded from MIP Technologies’ web-site, www.miptechnologies.com
|
|
Discovery of a selective phase for Fluoxetine and Paroxetine
- The concept of Cross reactivity in molecularly imprinted polymers
|
|
MIP materials are often referred to as synthetic receptors or antibodies. MIPs generated against a particular template may also recognize molecules that share similar chemical functionalities and/or molecular properties. In this study a selective phase for the antidepressant medicines fluoxetine and paroxetine was found.
Read more (.pdf)
|
|
|
MIP 2006 in Cardiff
|
|
On Sep 10-14th, researchers in the molecular imprinting area from all over the world met in Cardiff, UK to present and discuss their latest results at the 4th International Workshop on Molecular Imprinting.
The poster prize sponsored by MIP Technologies was awarded to Marinah M. Ariffin from the University of Glasgow for her poster entitled "Applications of MISPE for Benzodiazepine Extraction from Forensic Hair Samples".
Read more (.pdf)
Poster (.pdf)
|
|
|
|
|
|
|
|
|
Newsletter #4
|
|
|
Contents
- Extraction of Chloramphenicol from honey and urine
- Discovery of a selective phase for Fluoxetine and Paroxetine
- MIP 2006 in Cardiff
|
|
|
MIP[4]SPE™
Increased sensitivity and efficiency in SPE
Clenbuterol
Beta agonists
Beta blockers
Chloramphenicol
Riboflavin
Triazines
NNAL (Nicotine metabolite)
Download application notes from our web-site www.miptechnologies.com
|
|
|
MIP [4] Process™
Decrease the number of purification cycles and increase productivity by using extraction/separation materials from MIP Technologies.
Read more (.pdf)
|
|
|
|
Coming soon
MIP for TSNA extraction
A broad spectrum of tobacco specific nitrosamines in biological samples can be extracted for analytical applications with the TSNA MIP e.g. NNN, NNK, NAT, NAB.
Read more
You can register by email if you want information about product launch.
Register here
|
|
|
|
Updated applications for Beta agonist extraction
For increased recoveries and lowered detection limits - Check our updated application notes!
Extraction of Beta agonists from urine
Extraction of Beta agonists from muscle
|
|
|
Order on-line directly through MIP Technologies web-site
Try the MIP Technologies webshop.
|
|
|
MIP Technologies is a world leading company in the development of molecularly imprinted polymers (MIPs). The Company is a pioneer in the commercial applications of MIPs, holds important patents and maintains cutting edge research activities in the area. The Company's mission is to provide innovative products based on molecularly imprinted polymers that serve industry's needs in analytical, preparative and process scale 'selective separations'.
www.miptechnologies.com
|
|
|
|
